The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

Patients after organ transplantation have impaired immune response after vaccination against the SARS-CoV-2 virus. So far, published studies have reported quite different response rates to SARS-CoV-2 vaccination, ranging from 15–79% in liver and kidney transplant recipients. Up to one year after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautem, Anja, Boedecker-Lips, Simone Cosima, Schneider, Elisa, Runkel, Stefan, Feist, Christina, Lang, Hauke, Weinmann-Menke, Julia, Koch, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383075/
https://www.ncbi.nlm.nih.gov/pubmed/37513757
http://dx.doi.org/10.3390/pathogens12070910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383075/
https://www.ncbi.nlm.nih.gov/pubmed/37513757
http://dx.doi.org/10.3390/pathogens12070910

Ejemplares similares